Giant Cell Arteritis Clinical Trial

Giant cell arteritis is an inflammation of the lining of your arteries. Most often, it affects the arteries in your head, especially those in your temples. For this reason, giant cell arteritis is sometimes called temporal arteritis.

Symptoms include headaches and blurred or double vision. Prompt treatment is required to reduce the risk of serious complications including stroke, blindness and abdominal aortic aneurysm.

This study is evaluating an investigational medication to see if it may alleviate symptoms of Giant Cell Arteritis (GCA) in people who are currently taking glucocorticoids (such as prednisone). If effective, this may allow participants to taper off prednisone and prevent further side effects from long-term prednisone use.

Have you been diagnosed with Giant Cell Arteritis
Are you at least 50 years of age
Is your Giant cell Arteritis (GCA) either a new diagnosis or relapsing ie: back on steroids, an increase in steroid dose or return of symptoms?
Are you currently on steroids?

For more information on our clinical trials, please contact us.

Sponsors + Partners

+64 3 365 6777
enquiries@cgm.org.nz
Level 3, 800 Colombo Street
Christchurch Central City
Christchurch, 8013

For Participants
For Sponsors
About CGM Research Trust
Current Trials
Contact Us